Cargando…

Anaphylactic shock due to intra‐articular injection of diclofenac etalhyaluronate sodium: A case report

BACKGROUND: Anaphylactic shock of diclofenac etalhyaluronate agent can be prolonged and recurrent. However, its reports are rare, and consequently, its method of management remains to be established. CASE PRESENTATION: A 65‐year‐old woman received an intra‐articular injection of diclofenac and hyalu...

Descripción completa

Detalles Bibliográficos
Autores principales: Yatabe, Tomoaki, Mizutani, Akihito, Ito, Takashi, Ono Ricart, Yukika, Watanabe, Maasa, Uchiyama, Sohta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557470/
https://www.ncbi.nlm.nih.gov/pubmed/37808967
http://dx.doi.org/10.1002/ams2.898
_version_ 1785117096967929856
author Yatabe, Tomoaki
Mizutani, Akihito
Ito, Takashi
Ono Ricart, Yukika
Watanabe, Maasa
Uchiyama, Sohta
author_facet Yatabe, Tomoaki
Mizutani, Akihito
Ito, Takashi
Ono Ricart, Yukika
Watanabe, Maasa
Uchiyama, Sohta
author_sort Yatabe, Tomoaki
collection PubMed
description BACKGROUND: Anaphylactic shock of diclofenac etalhyaluronate agent can be prolonged and recurrent. However, its reports are rare, and consequently, its method of management remains to be established. CASE PRESENTATION: A 65‐year‐old woman received an intra‐articular injection of diclofenac and hyaluronate. After 20 min, systemic urticaria and severe hypotension developed after walking. After an intramuscular adrenaline injection, she was transferred to our hospital. Despite administration of continuous noradrenaline and adrenaline, hypotension persisted. Seven hours after the joint injection, 25 mL of knee joint fluid was aspirated under ultrasound guidance. Mobilization was performed 24 h after joint injection. However, urticaria rapidly spread after standing. At 45 and 46 h after joint injection, we confirmed that no symptoms, including urticaria, recurred after walking. CONCLUSION: Anaphylactic shock due to intra‐articular injection of diclofenac etalhyaluronate is prolonged and requires extended observation. Aspiration of joint fluid may be one of the treatment options.
format Online
Article
Text
id pubmed-10557470
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-105574702023-10-07 Anaphylactic shock due to intra‐articular injection of diclofenac etalhyaluronate sodium: A case report Yatabe, Tomoaki Mizutani, Akihito Ito, Takashi Ono Ricart, Yukika Watanabe, Maasa Uchiyama, Sohta Acute Med Surg Case Report BACKGROUND: Anaphylactic shock of diclofenac etalhyaluronate agent can be prolonged and recurrent. However, its reports are rare, and consequently, its method of management remains to be established. CASE PRESENTATION: A 65‐year‐old woman received an intra‐articular injection of diclofenac and hyaluronate. After 20 min, systemic urticaria and severe hypotension developed after walking. After an intramuscular adrenaline injection, she was transferred to our hospital. Despite administration of continuous noradrenaline and adrenaline, hypotension persisted. Seven hours after the joint injection, 25 mL of knee joint fluid was aspirated under ultrasound guidance. Mobilization was performed 24 h after joint injection. However, urticaria rapidly spread after standing. At 45 and 46 h after joint injection, we confirmed that no symptoms, including urticaria, recurred after walking. CONCLUSION: Anaphylactic shock due to intra‐articular injection of diclofenac etalhyaluronate is prolonged and requires extended observation. Aspiration of joint fluid may be one of the treatment options. John Wiley and Sons Inc. 2023-10-06 /pmc/articles/PMC10557470/ /pubmed/37808967 http://dx.doi.org/10.1002/ams2.898 Text en © 2023 The Authors. Acute Medicine & Surgery published by John Wiley & Sons Australia, Ltd on behalf of Japanese Association for Acute Medicine. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Case Report
Yatabe, Tomoaki
Mizutani, Akihito
Ito, Takashi
Ono Ricart, Yukika
Watanabe, Maasa
Uchiyama, Sohta
Anaphylactic shock due to intra‐articular injection of diclofenac etalhyaluronate sodium: A case report
title Anaphylactic shock due to intra‐articular injection of diclofenac etalhyaluronate sodium: A case report
title_full Anaphylactic shock due to intra‐articular injection of diclofenac etalhyaluronate sodium: A case report
title_fullStr Anaphylactic shock due to intra‐articular injection of diclofenac etalhyaluronate sodium: A case report
title_full_unstemmed Anaphylactic shock due to intra‐articular injection of diclofenac etalhyaluronate sodium: A case report
title_short Anaphylactic shock due to intra‐articular injection of diclofenac etalhyaluronate sodium: A case report
title_sort anaphylactic shock due to intra‐articular injection of diclofenac etalhyaluronate sodium: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557470/
https://www.ncbi.nlm.nih.gov/pubmed/37808967
http://dx.doi.org/10.1002/ams2.898
work_keys_str_mv AT yatabetomoaki anaphylacticshockduetointraarticularinjectionofdiclofenacetalhyaluronatesodiumacasereport
AT mizutaniakihito anaphylacticshockduetointraarticularinjectionofdiclofenacetalhyaluronatesodiumacasereport
AT itotakashi anaphylacticshockduetointraarticularinjectionofdiclofenacetalhyaluronatesodiumacasereport
AT onoricartyukika anaphylacticshockduetointraarticularinjectionofdiclofenacetalhyaluronatesodiumacasereport
AT watanabemaasa anaphylacticshockduetointraarticularinjectionofdiclofenacetalhyaluronatesodiumacasereport
AT uchiyamasohta anaphylacticshockduetointraarticularinjectionofdiclofenacetalhyaluronatesodiumacasereport